Roselyn J. Eisenberg

Last updated
Roselyn J. Eisenberg
EducationBiology, Bryn Mawr College, 1960 PhD, Microbiology, University of Pennsylvania, 1965
Alma materBryn Mawr College (BA) University of Pennsylvania (Ph.D)
Known forResearch of herpes simplex virus and poxvirus and how they enter susceptible cells
AwardsAmerican Academy of Microbiologists

American Association for the Advancement of Science

Member of Editorial Board for Journal of Virology

Contents

Scientific career
FieldsMicrobiology, virology
InstitutionsUniversity of Pennsylvania

Roselyn J. Eisenberg is a professor at The University of Pennsylvania and a member of the University's School of Veterinary Medicine and School of Dental Medicine. The majority of Eisenberg's research is focused on the herpes simplex virus and the poxvirus and how they enter into susceptible cells. [1] She also studies glycoproteins, vaccines, virology and microbiology.

Education

Eisenberg graduated from Bryn Mawr College in 1960 with her applied baccalaureate degree in biology. She went on to obtain her PhD in microbiology at the University of Pennsylvania, where she now works. Dr. Eisenberg did her post-doctoral fellowship at Princeton University from 1965 to 1968. She works closely beside Dr. Gary H. Cohen, who is a professor and the chair of the Department of Microbiology at Penn Dental Medicine. [1]

Research contributions

Eisenberg studies how molecular events mediate a virus' entry into a cell. Her research is focused mainly on the herpes simplex virus (herpesviridea) and the poxvirus. [1]

Herpesvirus

She is primarily interested in studying herpesviridae, which consists of enveloped DNA viruses that recruit orthologs, or genes that retain the same function, of three glycoproteins. These glycoproteins gB, gH, and gL play important roles in how a virus enters a cell and how it spreads when inside of a cell. [2] Eisenberg is interested in the fact that glycoproteins gH, gL and gB are very protected in all herpesviruses, especially in the large number of animal herpesviruses, which can cause disease in small, farm, and zoo animals.

Herpes simplex virus pap test 2 Herpes simplex virus pap test 2.jpg
Herpes simplex virus pap test 2

Poxvirus

She is also very focused on studying the poxvirus variola, also known as smallpox, and the virus that is used as a vaccine against variola, called vaccinia. Her main goal is to understand how this virus enters a cell and also to come up with a subunit vaccine that will expand upon and improve the current vaccine for variola, which can have serious side effects and may not be used on pregnant women or individuals with an impaired immune system. She is directing her focus to the entry protein L1, which she believes is the receptor binding protein for vaccina and will be able to improve limitations of the current vaccine for smallpox. [1]

Publications

She has contributed research and information to 264 articles and has been cited 784 times. [3] Below is a list of some of the publications she has taken part in.

Honors

Eisenberg was elected to the American Academy of Microbiologists and the American Association for the Advancement of Science to honor her contributions and leadership. [1] She is a member of the editorial board for the Journal of Virology . [10]

Related Research Articles

<span class="mw-page-title-main">Varicella zoster virus</span> Herpes virus that causes chickenpox and shingles

Varicella zoster virus (VZV), also known as human herpesvirus 3 or Human alphaherpesvirus 3 (taxonomically), is one of nine known herpes viruses that can infect humans. It causes chickenpox (varicella) commonly affecting children and young adults, and shingles in adults but rarely in children. VZV infections are species-specific to humans. The virus can survive in external environments for a few hours.

<span class="mw-page-title-main">Vaccinia</span> Strain of poxvirus

Vaccinia virus is a large, complex, enveloped virus belonging to the poxvirus family. It has a linear, double-stranded DNA genome approximately 190 kbp in length, which encodes approximately 250 genes. The dimensions of the virion are roughly 360 × 270 × 250 nm, with a mass of approximately 5–10 fg. The vaccinia virus is the source of the modern smallpox vaccine, which the World Health Organization (WHO) used to eradicate smallpox in a global vaccination campaign in 1958–1977. Although smallpox no longer exists in the wild, vaccinia virus is still studied widely by scientists as a tool for gene therapy and genetic engineering.

<i>Poxviridae</i> Family of viruses

Poxviridae is a family of double-stranded DNA viruses. Vertebrates and arthropods serve as natural hosts. There are currently 83 species in this family, divided among 22 genera, which are divided into two subfamilies. Diseases associated with this family include smallpox.

Orthopoxvirus is a genus of viruses in the family Poxviridae and subfamily Chordopoxvirinae. Vertebrates, including mammals and humans, and arthropods serve as natural hosts. There are 12 species in this genus. Diseases associated with this genus include smallpox, cowpox, horsepox, camelpox, and mpox. The most widely known member of the genus is Variola virus, which causes smallpox. It was eradicated globally by 1977, through the use of Vaccinia virus as a vaccine. The most recently described species is the Alaskapox virus, first isolated in 2015.

<i>Herpesviridae</i> Family of DNA viruses

Herpesviridae is a large family of DNA viruses that cause infections and certain diseases in animals, including humans. The members of this family are also known as herpesviruses. The family name is derived from the Greek word ἕρπειν, referring to spreading cutaneous lesions, usually involving blisters, seen in flares of herpes simplex 1, herpes simplex 2 and herpes zoster (shingles). In 1971, the International Committee on the Taxonomy of Viruses (ICTV) established Herpesvirus as a genus with 23 viruses among four groups. As of 2020, 115 species are recognized, all but one of which are in one of the three subfamilies. Herpesviruses can cause both latent and lytic infections.

<span class="mw-page-title-main">Herpes simplex virus</span> Species of virus

Herpes simplex virus1 and 2, also known by their taxonomic names Human alphaherpesvirus 1 and Human alphaherpesvirus 2, are two members of the human Herpesviridae family, a set of viruses that produce viral infections in the majority of humans. Both HSV-1 and HSV-2 are very common and contagious. They can be spread when an infected person begins shedding the virus.

<span class="mw-page-title-main">Poliovirus receptor-related 1</span> Protein-coding gene in the species Homo sapiens

Poliovirus receptor-related 1 (PVRL1), also known as nectin-1 and CD111 (formerly herpesvirus entry mediator C, HVEC) is a human protein of the immunoglobulin superfamily (IgSF), also considered a member of the nectins. It is a membrane protein with three extracellular immunoglobulin domains, a single transmembrane helix and a cytoplasmic tail. The protein can mediate Ca2+-independent cellular adhesion further characterizing it as IgSF cell adhesion molecule (IgSF CAM).

<span class="mw-page-title-main">Herpesvirus entry mediator</span> Protein-coding gene in the species Homo sapiens

Herpesvirus entry mediator (HVEM), also known as tumor necrosis factor receptor superfamily member 14 (TNFRSF14), is a human cell surface receptor of the TNF-receptor superfamily encoded by the TNFRSF14 gene.

Anthony (Tony) Charles Minson, PhD, FMedSci is a British virologist known for his work on the biology of herpesviruses, and a university administrator. He was the Senior Pro-Vice-Chancellor of the University of Cambridge from 2003 to 2009. He is an emeritus professor of virology at the university's Department of Pathology and an emeritus fellow of Wolfson College.

Sarah A. Connolly is an American virologist. She graduated with a PhD from the University of Pennsylvania in 2003 and is notable for her work on Paramyxovirus and Herpes virus.

Enzo Paoletti was an Italian-American virologist who developed the technology to express foreign antigens in vaccinia and other poxviruses. This advance led to the development of vaccines against multiple disease-causing pathogens.

<span class="mw-page-title-main">Herpesvirus glycoprotein B</span> Viral glycoprotein

Herpesvirus glycoprotein B is a viral glycoprotein that is involved in the viral cell entry of Herpes simplex virus (HSV). Herpesviruses have a lipid bilayer, called the envelope, which contains twelve surface glycoproteins. For infectivity to be attained, the double stranded DNA genome of HSV must enter the host cell through means of fusion of its envelope with the cellular membrane or via endocytosis. Other viral glycoproteins involved in the process of viral cell entry include gC, gB, gD, gH, and gL, but only gC, gB, gD, and gH are required for the fusion of the HSV's envelope with the cellular membrane. It can be noted that all herpesviruses have glycoproteins gB, gH, and gL.

MVA-B, or Modified Vaccinia Ankara B, is an HIV vaccine created to give immune resistance to infection by the human immunodeficiency virus. It was developed by a team of Spanish researchers at the Spanish National Research Council's Biotechnology National Centre headed by Dr. Mariano Esteban. The vaccine is based on the Modified vaccinia Ankara (MVA) virus used during the 1970s to help eradicate the smallpox virus. The B in the name "refers to HIV-B, the most common HIV subtype in Europe". It has been stated by Dr. Esteban that, in the future, the vaccine could potentially reduce the virulence of HIV to a "minor chronic infection akin to herpes".

David Mahan Knipe is the Higgins Professor of Microbiology and Molecular Genetics in the Department of Microbiology at the Harvard Medical School in Boston, Massachusetts and co-chief editor of the reference book Fields Virology. He returned to the Chair of the Program in Virology at Harvard Medical School in 2019, having previously held the position from 2004 through 2016 and served as interim Co-Chair of the Microbiology and Immunobiology Department from 2016 through 2018.

Almyra Oveta Fuller was an associate professor of microbiology and immunology at University of Michigan Medical School. She served as the director of the African Studies Center (ASC), faculty in the ASC STEM Initiative at the University of Michigan (U-M) and an adjunct professor at Payne Theological Seminary. Fuller was a virologist and specialized in research of Herpes simplex virus, as well as HIV/AIDS. Fuller and her research team discovered a B5 receptor, advancing the understanding of Herpes simplex virus and the cells it attacks.

Gabriella Campadelli-Fiume is a virologist with a primary research focus on herpes simplex virus, fusion and viral entry. She is a retired professor of virology from the University of Bologna, Italy.

Raccoonpox virus (RCN) is a double-stranded DNA virus and a member of the orthopoxviruses in the family Poxviridae and subfamily Chordopoxvirinae which consists of eight genera: Avipoxvirus, Capripoxvirus, Leporipoxvirus, Molluscipoxvirus, Orthopoxvirus, Parapoxvirus, Suipoxvirus and Yatapoxvirus Vertebrates are the natural host of Chordopoxvirinae subfamily viruses. More specifically, raccoons are the natural hosts of RCN. RCN was isolated in 1961 from the upper respiratory tissues of 2 raccoons in a group of 92 observably healthy raccoons trapped close to Aberdeen, Maryland.

Patricia Gail Spear is an American virologist. She is a professor emeritus of microbiology and immunology at Northwestern University in Evanston, Illinois. She is best known for her pioneering work studying the herpes simplex virus. Spear is a past president of the American Society for Virology and an elected member of the National Academy of Sciences.

Beate Sodeik is a German cell biologist who is Professor of Medical Sciences at the Hannover Medical School. Her research considers the biology of viral infections, with a particular focus on Herpes simplex virus.

Jay Clark Brown is an American molecular biologist, microbiologist, virologist, and academic. He is a Professor Emeritus in the Department of microbiology, immunology, and cancer biology at the University of Virginia School of Medicine.

References

  1. 1 2 3 4 5 "Biomedical Graduate Studies". University of Pennsylvania. The Trustees of the University of Pennsylvania. Retrieved 15 April 2015.
  2. Eisenberg, R.J.; Atanasiu, D.; Cairns, T.M.; Gallagher, J.R.; Krummenacher, C.; Cohen, G.H. (May 10, 2012). "Herpes virus fusion and entry: a story with many characters". Viruses. 4 (5): 800–832. doi: 10.3390/v4050800 . PMC   3386629 . PMID   22754650.
  3. Eisenberg, R. "Roselyn J. Eisenberg". Google Scholar. Retrieved 15 May 2015.
  4. Heldwein, Ekaterina; Lou, Haun; Bender, Florent; Cohen, Gary; Eisenberg, Roselyn; Harrison, Stephen (14 July 2006). "Crystal Structure of Glycoprotein B from Herpes Simplex Virus 1". Science. 313 (5784): 217–20. Bibcode:2006Sci...313..217H. CiteSeerX   10.1.1.412.1906 . doi:10.1126/science.1126548. PMID   16840698. S2CID   15532098.
  5. Xiao, Yuhong; Aldaz-Carroll, Lydia; Ortiz, Alexandra; Whitbeck, Charles; Alexander, Edward; Lou, Huan; Davis, Heather; Braciale, Thomas; Eisenberg, Roselyn; Cohen, Gary; Isaacs, Stuart (26 January 2007). "A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost". Vaccine. 25 (7): 1214–24. doi:10.1016/j.vaccine.2006.10.009. PMC   1857298 . PMID   17098336.
  6. Atanasiu, D; Whitbeck, J.C; Cairns, T.M; Reilly, B; Cohen, G; Eisenberg, R (14 November 2007). "Bimolecular complementation reveals that glycoproteins gB and gH/gL of herpes simplex virus interact with each other during cell fusion". Proc Natl Acad Sci U S A. 104 (47): 18718–23. Bibcode:2007PNAS..10418718A. doi: 10.1073/pnas.0707452104 . PMC   2141843 . PMID   18003913.
  7. Foo, C.H.; Whitbeck, J.C.; Ponce-de-Leon, M.; Saw, W.T.; Cohen, G.H.; Eisenberg, R.J. (7 March 2012). "The myristate moiety and amino terminus of vaccinia virus l1 constitute a bipartite functional region needed for entry". Journal of Virology. 86 (10): 5437–51. doi:10.1128/JVI.06703-11. PMC   3347306 . PMID   22398293.
  8. Lazear, E.; Whitbeck, C.J.; Ponce-de-Leon, M.; Cairns, T.M.; Willis, S.H.; Zuo, Y.; Krummenacher, C.; Cohen, G.H.; Eisenberg, R.J. (February 2012). "Antibody-induced conformational changes in herpes simplex virus glycoprotein gD reveal new targets for virus neutralization". Journal of Virology. 86 (3): 1563–76. doi:10.1128/jvi.06480-11. PMC   3264331 . PMID   22130533.
  9. Cairns, T.; Whitbeck, C.; Lou, H.; Heldwein, E.; Chowdary, T.; Eisenberg, R.; Cohen, G. (July 2011). "Capturing the Herpes Simplex Virus Core Fusion Complex (gB-gH/gL) in an Acidic Environment". Journal of Virology. 85 (13): 6175–84. doi:10.1128/JVI.00119-11. PMC   3126480 . PMID   21507973.
  10. Eisenberg, R. "Journal of Virology, Editorial Board". American Society for Microbiology. Journal of Virology. Retrieved 15 May 2015.